Analysis of US FDA-approved drugs containing sulfur atoms

KA Scott, JT Njardarson - Sulfur Chemistry, 2019 - Springer
In this review, we discuss all sulfur-containing FDA-approved drugs and their structures. The
second section of the review is dedicated to structural analysis and is divided into 14 …

Chemokine (C–X–C motif) ligand (CXCL) 10 in autoimmune diseases

A Antonelli, SM Ferrari, D Giuggioli, E Ferrannini… - Autoimmunity …, 2014 - Elsevier
Abstract (C–X–C motif) ligand (CXCL) 10 (CXCL10) belongs to the ELR− CXC subfamily
chemokine. CXCL10 exerts its function through binding to chemokine (C–X–C motif) …

[HTML][HTML] Synergistic effect of IFN-γ and IL-1β on PD-L1 expression in hepatocellular carcinoma

Y Numata, N Akutsu, K Ishigami, H Koide… - … and Biophysics Reports, 2022 - Elsevier
Immunotherapy using anti-programmed death 1 ligand 1 (PD-L1) antibodies has shown
clinical efficacy against hepatocellular carcinoma (HCC) and is recognized as the first-line …

[HTML][HTML] Chemokines in thyroid autoimmunity

SM Ferrari, SR Paparo, F Ragusa, G Elia… - Best Practice & …, 2023 - Elsevier
The chemokine receptor CXCR3 and its chemokines CXCL9, CXCL10, and CXCL11 are
involved in the pathogenesis of autoimmune diseases. Th1 lymphocytes are recruited by …

CXCL10: a candidate biomarker in transplantation

P Romagnani, C Crescioli - Clinica chimica acta, 2012 - Elsevier
Interferon (IFN) γ-induced protein 10kDa (IP-10) or CXC motif chemokine 10 (CXCL10) is a
small cytokine belonging to the CXC chemokine family. This family of signaling molecules is …

Modulation of ACE-2 mRNA by inflammatory cytokines in human thyroid cells: a pilot study

F Coperchini, G Ricci, L Croce, M Denegri, R Ruggiero… - Endocrine, 2021 - Springer
Abstract Introduction Angiotensin-converting-enzyme-2 (ACE-2) was demonstrated to be the
receptor for cellular entry of SARS-CoV-2. ACE-2 mRNA was identified in several human …

Novel therapies for thyroid autoimmune diseases: An update

SM Ferrari, P Fallahi, G Elia, F Ragusa… - Best Practice & …, 2020 - Elsevier
A Th1 immune-preponderance has been shown in the immunopathogenesis of autoimmune
thyroiditis (AT), Graves' disease (GD) and Graves' Ophthalmopathy (GO), in which the Th1 …

Monokine induced by interferon γ (IFNγ)(CXCL9) and IFNγ inducible T-cell α-chemoattractant (CXCL11) involvement in graves' disease and ophthalmopathy …

A Antonelli, SM Ferrari, P Fallahi… - The Journal of …, 2009 - academic.oup.com
Context: CXC α-chemokine CXCL10/IP-10 plays an important role in the initial phases of
Graves' ophthalmopathy (GO). Human thyrocytes, orbital fibroblasts, and preadipocytes are …

chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets

AJ Czaja - Alimentary pharmacology & therapeutics, 2014 - Wiley Online Library
Background Chemokines contribute to the pathogenesis of autoimmune hepatitis by
directing the migration and positioning of inflammatory and immune cells within the liver …

Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target

C Crescioli, M Sottili, P Bonini, L Cosmi… - European Journal of …, 2012 - Elsevier
Inflammatory myopathies (IMs) are systemic diseases characterized by a T helper (Th) 1
type inflammatory response and cell infiltrates within skeletal muscles. The mainstay of …